Vaxcyte, Inc.
A clinical-stage company developing broad-spectrum vaccines for bacterial infectious diseases.
PCVX | US
Overview
Corporate Details
- ISIN(s):
- US92243G1085
- LEI:
- Country:
- United States of America
- Address:
- 825 INDUSTRIAL ROAD, STE. 300, 94070 SAN CARLOS
- Website:
- https://vaxcyte.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vaxcyte, Inc. is a clinical-stage vaccine company focused on preventing and treating bacterial infectious diseases. The company utilizes its proprietary cell-free protein synthesis platform, along with advanced chemistry and modern synthetic techniques, to engineer high-fidelity, broad-spectrum vaccines. Its lead candidates are VAX-24 and VAX-31, next-generation pneumococcal conjugate vaccines (PCVs) designed to offer broader protection against invasive pneumococcal disease, particularly for young children and older adults. Vaxcyte's pipeline also includes early-stage development programs for vaccines targeting Group A Strep and Shigella, aiming to set a new standard of care in bacterial disease prevention.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Vaxcyte, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vaxcyte, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vaxcyte, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
